Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Jul 30, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2019. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 4.0B USD
- Positions
- 229
- Share of the ten largest
- 50.0%
The ten largest positions Q2 2019
- Lendingclub Corp 8.5%new
- Tesla, Inc. 6.5%▲ +54.3%
- Stratasys Ltd 5.7%▲ +6.2%
- Invitae Corp 5.6%▲ +7.9%
- Illumina, Inc. 5.0%▲ +15.1%
- Block, Inc. 4.6%▲ +17.5%
- Nvidia 4.4%▼ −16.9%
- Intellia Therapeutics Inc 3.4%▲ +3.3%
- Crispr Therapeutics AG 3.2%▲ +34.7%
- Editas Medicine Inc 3.0%▲ +6.3%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q2 2019
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| TSLA Tesla, Inc. | 6.5% | 1,163,182 | 259.9M USD | +54.3% increased | Q4 2016 or earlier 11 quarters |
| Stratasys Ltd | 5.7% | 7,711,945 | 226.5M USD | +6.2% increased | Q4 2016 or earlier 11 quarters |
| Invitae Corp | 5.6% | 9,423,157 | 221.4M USD | +7.9% increased | Q4 2016 or earlier 11 quarters |
| ILMN Illumina, Inc. | 5.0% | 537,531 | 197.9M USD | +15.1% increased | Q4 2016 or earlier 11 quarters |
| XYZ Block, Inc. | 4.6% | 2,506,643 | 181.8M USD | +17.5% increased | Q4 2016 or earlier 11 quarters |
| Intellia Therapeutics Inc | 3.4% | 8,243,165 | 134.9M USD | +3.3% increased | Q4 2016 or earlier 11 quarters |
| Crispr Therapeutics AG | 3.2% | 2,724,349 | 128.3M USD | +34.7% increased | Q2 2017 9 quarters |
| Editas Medicine Inc | 3.0% | 4,848,148 | 119.9M USD | +6.3% increased | Q1 2017 10 quarters |
| Nanostring Technologies Inc | 2.7% | 3,526,095 | 107.0M USD | +1.4% increased | Q4 2016 or earlier 11 quarters |
| Spotify Technology SA | 1.8% | 496,384 | 72.6M USD | +8.9% increased | Q2 2018 5 quarters |
| Teladoc Inc | 1.6% | 977,559 | 64.9M USD | +32.7% increased | Q3 2017 8 quarters |
| Splunk Inc | 1.6% | 507,306 | 63.8M USD | +20.4% increased | Q4 2016 or earlier 11 quarters |
| CRM Salesforce | 1.6% | 412,434 | 62.6M USD | +18.6% increased | Q4 2016 or earlier 11 quarters |
| Xilinx Inc | 1.4% | 470,634 | 55.5M USD | +361.5% increased | Q4 2016 or earlier 11 quarters |
| Proto Labs Inc | 1.4% | 470,848 | 54.6M USD | +61.7% increased | Q4 2016 or earlier 11 quarters |
| Materialise Nv-Adr | 1.4% | 2,792,678 | 54.5M USD | +1.6% increased | Q4 2016 or earlier 11 quarters |
| 2U Inc | 1.3% | 1,403,952 | 52.8M USD | +171.3% increased | Q4 2016 or earlier 11 quarters |
| Cerus Corp | 1.2% | 8,493,022 | 47.7M USD | +11.2% increased | Q4 2016 or earlier 11 quarters |
| Nutanix Inc - A | 0.9% | 1,412,100 | 36.6M USD | +651.0% increased | Q1 2019 2 quarters |
| Syros Pharmaceuticals Inc | 0.9% | 3,791,756 | 35.1M USD | +26.7% increased | Q4 2016 or earlier 11 quarters |
| Compugen Ltd | 0.8% | 8,496,641 | 32.6M USD | +3.2% increased | Q4 2016 or earlier 11 quarters |
| Eventbrite Inc-Class A | 0.7% | 1,647,777 | 26.7M USD | +125.1% increased | Q4 2018 3 quarters |
| BABA Alibaba Group (ADR) | 0.6% | 152,159 | 25.8M USD | +16.3% increased | Q4 2016 or earlier 11 quarters |
| Seres Therapeutics Inc | 0.6% | 7,038,885 | 22.7M USD | +33.1% increased | Q4 2016 or earlier 11 quarters |
| Exone Co/The | 0.5% | 2,304,554 | 21.5M USD | +6.1% increased | Q4 2016 or earlier 11 quarters |
| IOVA Iovance Biotherapeutics | 0.5% | 807,688 | 19.8M USD | +16.8% increased | Q1 2018 6 quarters |
| Cellectis - ADR | 0.4% | 1,103,186 | 17.2M USD | +18.1% increased | Q1 2017 10 quarters |
| BMY Bristol Myers Squibb | 0.4% | 352,421 | 16.0M USD | +81.4% increased | Q1 2019 2 quarters |
| PDD PDD Holdings | 0.3% | 667,560 | 13.8M USD | +62.9% increased | Q4 2018 3 quarters |
| Cloudera Inc | 0.3% | 2,544,376 | 13.4M USD | +68.2% increased | Q1 2019 2 quarters |
| Inovio Pharmaceuticals Inc | 0.3% | 3,955,017 | 11.6M USD | +35.0% increased | Q4 2016 or earlier 11 quarters |
| INCY Incyte | 0.3% | 130,737 | 11.1M USD | +94.2% increased | Q4 2016 or earlier 11 quarters |
| Organovo Holdings Inc | 0.3% | 21,132,709 | 11.1M USD | +5.7% increased | Q4 2016 or earlier 11 quarters |
| Rubius Therapeutics Inc | 0.3% | 698,402 | 11.0M USD | +31.9% increased | Q3 2018 4 quarters |
| Aerovironment Inc | 0.3% | 181,776 | 10.3M USD | +49.7% increased | Q4 2016 or earlier 11 quarters |
| REGN Regeneron Pharmaceuticals | 0.2% | 28,593 | 9.0M USD | +116.0% increased | Q4 2016 or earlier 11 quarters |
| TWLO Twilio | 0.2% | 59,405 | 8.1M USD | +26.0% increased | Q4 2018 3 quarters |
| Codexis Inc | 0.2% | 337,288 | 6.2M USD | +8.3% increased | Q4 2018 3 quarters |
| Cellular Biomedicine Group I | 0.1% | 314,378 | 5.2M USD | +10.0% increased | Q1 2019 2 quarters |
| JD JD.com (ADR) | 0.1% | 147,325 | 4.5M USD | +104.0% increased | Q3 2017 8 quarters |
| Slm Solutions Group AG | < 0.1% | 246,474 | 3.6M USD | +39.3% increased | Q3 2017 8 quarters |
| Cognex Corp | < 0.1% | 71,574 | 3.4M USD | +3.8% increased | Q4 2017 7 quarters |
| Kratos Defense & Security | < 0.1% | 136,624 | 3.1M USD | +13.9% increased | Q3 2018 4 quarters |
| TSM Taiwan Semiconductor Manufacturing (ADR) | < 0.1% | 74,861 | 2.9M USD | +4.2% increased | Q1 2018 6 quarters |
| ISRG Intuitive Surgical | < 0.1% | 5,434 | 2.9M USD | +10.3% increased | Q2 2018 5 quarters |
| Rakuten Inc Jpy Ord | < 0.1% | 220,805 | 2.6M USD | +27.6% increased | Q4 2017 7 quarters |
| HPQ HP Inc. | < 0.1% | 125,529 | 2.6M USD | +33.7% increased | Q4 2016 or earlier 11 quarters |
| INTU Intuit | < 0.1% | 8,312 | 2.2M USD | +35.3% increased | Q2 2017 9 quarters |
| Sbi Holdings Inc Tokyo | < 0.1% | 85,400 | 2.1M USD | +14.8% increased | Q4 2017 7 quarters |
| DE Deere & Company | < 0.1% | 12,727 | 2.1M USD | +19.5% increased | Q3 2017 8 quarters |
| Line Corp | < 0.1% | 75,354 | 2.1M USD | +94.8% increased | Q1 2019 2 quarters |
| 3D Systems Corp | < 0.1% | 226,193 | 2.1M USD | +26.8% increased | Q4 2016 or earlier 11 quarters |
| Guidewire Software Inc | < 0.1% | 17,914 | 1.8M USD | +2.1% increased | Q4 2017 7 quarters |
| IBKR Interactive Brokers | < 0.1% | 26,894 | 1.5M USD | +37.2% increased | Q4 2017 7 quarters |
| Wirecard AG | < 0.1% | 8,344 | 1.4M USD | +18.9% increased | Q1 2019 2 quarters |
| ICE Intercontinental Exchange | < 0.1% | 15,515 | 1.3M USD | +19.0% increased | Q1 2018 6 quarters |
| Adyen NV | < 0.1% | 1,712 | 1.3M USD | +24.2% increased | Q1 2019 2 quarters |
| Zhongan Online P&C Insuran-H | < 0.1% | 459,900 | 1.3M USD | +18.9% increased | Q1 2019 2 quarters |
| Aquabounty Technologies | < 0.1% | 363,360 | 1.1M USD | +8.3% increased | Q1 2018 6 quarters |
| TransUnion | < 0.1% | 14,183 | 1.0M USD | +12.4% increased | Q4 2017 7 quarters |
| HDFC Bank Ltd | < 0.1% | 7,806 | 1.0M USD | +17.4% increased | Q4 2017 7 quarters |
| NDAQ Nasdaq, Inc. | < 0.1% | 9,647 | 928.0K USD | +16.6% increased | Q4 2017 7 quarters |
| Firstrand Ltd | < 0.1% | 185,282 | 900.0K USD | +14.8% increased | Q4 2017 7 quarters |
| SCHW Charles Schwab Corporation | < 0.1% | 20,100 | 808.0K USD | +16.8% increased | Q4 2017 7 quarters |
| Moog Inc | < 0.1% | 8,224 | 770.0K USD | +57.1% increased | Q1 2018 6 quarters |
| Bezeq The Israeli Telecom Co | < 0.1% | 665,306 | 505.0K USD | +32.2% increased | Q4 2017 7 quarters |
| Radcom Ltd | < 0.1% | 59,552 | 490.0K USD | +3.5% increased | Q4 2017 7 quarters |
| Urogen Pharma Ltd | < 0.1% | 13,529 | 486.0K USD | +50.2% increased | Q4 2017 7 quarters |
| Line Corp ADR | < 0.1% | 16,412 | 462.0K USD | +129.0% increased | Q4 2018 3 quarters |
| Gilat Satellite Networks Ltd | < 0.1% | 54,388 | 460.0K USD | +7.3% increased | Q4 2017 7 quarters |
| Galmed Pharmaceuticals Ltd | < 0.1% | 60,948 | 448.0K USD | +13.4% increased | Q3 2018 4 quarters |
| Ceragon Networks Ltd | < 0.1% | 131,354 | 385.0K USD | +12.3% increased | Q4 2017 7 quarters |
| Foamix Pharmaceuticals Ltd | < 0.1% | 146,745 | 349.0K USD | +25.0% increased | Q4 2017 7 quarters |
| Intec Pharma Ltd | < 0.1% | 77,348 | 336.0K USD | +38.5% increased | Q3 2018 4 quarters |
| Cellcom Israel Ltd | < 0.1% | 110,305 | 319.0K USD | +29.8% increased | Q4 2017 7 quarters |
| Teva Pharmaceutical-Sp ADR | < 0.1% | 34,407 | 318.0K USD | +40.7% increased | Q4 2017 7 quarters |
| Wirecard AG | < 0.1% | 3,559 | 298.0K USD | +9.8% increased | Q4 2017 7 quarters |
| Toray Industries Inc | < 0.1% | 7,196 | 55.0K USD | +12.5% increased | Q3 2017 8 quarters |
| Polyone Corporation | < 0.1% | 1,720 | 54.0K USD | +14.1% increased | Q4 2016 or earlier 11 quarters |
| Allegheny Technologies Inc | < 0.1% | 1,983 | 50.0K USD | +4.5% increased | Q4 2016 or earlier 11 quarters |
| Eastman Kodak Co | < 0.1% | 20,712 | 50.0K USD | +37.4% increased | Q4 2016 or earlier 11 quarters |
| Eastman Chemical Co | < 0.1% | 616 | 48.0K USD | +4.4% increased | Q4 2016 or earlier 11 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Technology 9.2%
- Consumer Discretionary 7.3%
- Health Care 6.6%
- Financials 5.1%
- Communication Services 1.9%
- Industrials 0.1%
- Materials 0.0%
- not in our coverage 69.7%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors